Head to Head Contrast: ASP Isotopes (NASDAQ:ASPI) versus International Flavors & Fragrances (NYSE:IFF)

ASP Isotopes (NASDAQ:ASPI) and International Flavors & Fragrances (NYSE:IFF) are both materials companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, valuation, analyst recommendations and dividends.

Risk and Volatility

ASP Isotopes has a beta of 3.59, meaning that its stock price is 259% more volatile than the S&P 500. Comparatively, International Flavors & Fragrances has a beta of 0.94, meaning that its stock price is 6% less volatile than the S&P 500.

Earnings & Valuation

This table compares ASP Isotopes and International Flavors & Fragrances”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ASP Isotopes	$23.85 million	21.28	-$175.09 million	($1.32)	-2.51
International Flavors & Fragrances	$10.89 billion	1.96	-$361.00 million	$1.09	76.76

ASP Isotopes has higher earnings, but lower revenue than International Flavors & Fragrances. ASP Isotopes is trading at a lower price-to-earnings ratio than International Flavors & Fragrances, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of recent ratings for ASP Isotopes and International Flavors & Fragrances, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ASP Isotopes	1	0	2	0	2.33
International Flavors & Fragrances	1	6	12	0	2.58

ASP Isotopes currently has a consensus price target of $13.00, indicating a potential upside of 292.75%. International Flavors & Fragrances has a consensus price target of $91.40, indicating a potential upside of 9.24%. Given ASP Isotopes’ higher possible upside, analysts plainly believe ASP Isotopes is more favorable than International Flavors & Fragrances.

Insider and Institutional Ownership

16.8% of ASP Isotopes shares are held by institutional investors. Comparatively, 96.0% of International Flavors & Fragrances shares are held by institutional investors. 14.4% of ASP Isotopes shares are held by insiders. Comparatively, 1.1% of International Flavors & Fragrances shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Profitability

This table compares ASP Isotopes and International Flavors & Fragrances’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
ASP Isotopes	-427.98%	-64.99%	-32.20%
International Flavors & Fragrances	2.78%	7.11%	3.96%

Summary

International Flavors & Fragrances beats ASP Isotopes on 9 of the 14 factors compared between the two stocks.

About ASP Isotopes

ASP Isotopes Inc., a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc. was incorporated in 2021 and is headquartered in Washington, District Of Columbia.

About International Flavors & Fragrances

International Flavors & Fragrances, Inc. engages in the manufacture and supply of flavors and fragrances used in the food, beverage, personal care, and household products industries. It operates through the following segments: Nourish, Health & Biosciences, Scent and Pharma Solutions. The Nourish segment consists of legacy Taste segment combined with N&B’s Food & Beverage division and the food protection business of N&B’s Health & Biosciences division. The Health & Biosciences business consists of a biotechnology-driven portfolio of enzymes, food cultures, probiotics and specialty ingredients for food, home and personal care, and health and wellness applications. The Scent business creates fragrance compounds, fragrance ingredients and cosmetic ingredients that are integral elements in the world’s finest perfumes and best-known household and personal care products. The Pharma Solutions business produces a vast portfolio including cellulosics and seaweed-based pharma excipients, used to improve the functionality and delivery of active pharmaceutical ingredients, including controlled or modified drug release formulations, and enabling. The company was founded in 1833 and is headquartered in New York, NY.